Fingerprint
Dive into the research topics of 'Allo-SCT for AML and MDS with treosulfan compared with BU-based regimens: Reduced toxicity vs reduced intensity'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Allo-SCT for AML and MDS with treosulfan compared with BU-based regimens: Reduced toxicity vs reduced intensity
A. Shimoni*, N. Shem-Tov, Y. Volchek, I. Danylesko, R. Yerushalmi, A. Nagler
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
48
Scopus
citations